Brit Mollenhauer

University of Pittsburgh — United States

Medicine · Health Sciences

92h-index39.0kcitations473works17.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Parkinson's Disease Mechanisms and Treatments(319), Neurological disorders and treatments(152), Alzheimer's disease research and treatments(84), Dementia and Cognitive Impairment Research(43), Neurological diseases and metabolism(40)

Publications463 total

Resistant starch improves Parkinson’s disease symptoms through restructuring of the gut microbiome and modulating inflammation
Brain Behavior and Immunity·2025Open Access
Genome-wide association study of REM-sleep behaviour disorder identifies new risk loci
2025Open Access
Proteomic Exploration of L1CAM+-Extracellular Vesicles from Plasma of Manifest and Prodromal Parkinson’s Disease
International Journal of Molecular Sciences·2025Open Access
How many do we miss? - Evaluation of age at onset and family history as selection criteria for genetic testing in Parkinson’s disease
2025Open Access
Synphilin-1 modulates alpha-synuclein assembly, release and uptake
npj Parkinson s Disease·2025Open Access
Diagnostic and other biomarkers of dementia with Lewy bodies: from research to clinical settings
The Lancet Neurology·2025Open Access
Expanding the human metaproteome: enhancing small open reading frame (smORF) prediction and ultra-deep detection of smORF-encoded proteins in the gut microbiome
2025Open Access
Clinical and imaging characteristics of Parkinson’s disease with negative alpha-synuclein seed amplification assay
2025Open Access
Sleep stage mixing is associated with poor prognosis in early Parkinson’s disease
npj Parkinson s Disease·2025Open Access
Fasting followed by time-restricted eating leads to sustained symptom improvement in patients with Parkinson’s disease
Clinical Nutrition ESPEN·2025
An immuno-Infrared Sensor detects preclinical Alzheimer's and Parkinson's Disease by misfolding
arXiv (Cornell University)·2025Open Access
Post-traumatic stress disorder and REM-sleep behavior disorder: exploring genetic associations and causal links
2025Open Access
A Novel α‐Synuclein <scp>K58N</scp> Missense Variant in a Patient with Parkinson's Disease
Movement Disorders·2025· 1 citedOpen Access
Impact assessment of dissemination techniques on data collection in a large multicenter Healthy Brain Ageing (HeBA) survey (Preprint)
2025Open Access
Progression to Parkinson's dementia is not modulated by genetic risk variants for Alzheimer's or Parkinson's disease
Journal of Parkinson s Disease·2025Open Access
Human gut microbiome gene co-expression network reveals a loss in taxonomic and functional diversity in Parkinson’s disease
npj Biofilms and Microbiomes·2025· 3 citedOpen Access
Cognitive Performance in Early Neuronal Synuclein Disease with Hyposmia but without Motor Disability: Association with Dopamine Deficiency and Isolated Rapid Eye Movement Sleep Behavior Disorder
Annals of Neurology·2025· 1 citedOpen Access
Fasting-driven suppression of disease activity in rheumatoid arthritis
2025· 1 citedOpen Access
Differential pathological dynamics triggered by distinct Parkinson patient–derived α-synuclein extracts in nonhuman primates
Science Advances·2025· 2 citedOpen Access
Alpha-synuclein misfolding as fluid biomarker for Parkinson’s disease measured with the iRS platform
EMBO Molecular Medicine·2025· 8 citedOpen Access
page 1 of 24Next →

Frequent Co-authors

Claudia Trenkwalder(17), Daniel Weintraub(11), Andrew Singleton(8), Kenneth Marek(8), Tanya Simuni(8), Friederike Sixel‐Döring(8), Niels Kruse(8), Omar M. A. El‐Agnaf(7), Douglas Galasko(7), John Q. Trojanowski(7), Andrew Siderowf(7), Caroline M. Tanner(7), Mark Frasier(7), Dag Aarsland(6), Ronald B. Postuma(6), John Seibyl(6), David J. Burn(5), Jennifer G. Goldman(5), Irene Litvan(5), Werner Poewe(5)